We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Check the tariff classification for peptide nisin standardised with sodium chloride
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Use the online service or postal form HO55 to claim a partial repayment of the rebated excise duty on oil used as fuel to produce energy for the treatment or production of mineral oil.
BBVU offers laboratory reference services and carries out research and development on hepatitis viruses, and has a remit for blood safety.
The review of the safety of isotretinoin has concluded.
This series brings together all documents relating to Guidance and methods
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
This guidance specifies the standards for the continuous monitoring and sampling of stack emissions.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Potential effects on performance of prescription and or over the counter drugs.
Industrial Injuries Disablement Benefit claim forms to print and fill in with a pen.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
Policy and guidance for prisons on the effective treatment of prisoners who need help with substance misuse.
Diagnosis and epidemiology of Mycoplasma pneumoniae.
B. Braun Medical Limited is recalling various product batches as a precautionary measure after traces of midazolam were detected in the batches listed in this notification.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.